1-5 of 5
Joost S. P. Vermaat
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment strategies and outcome in relapsed peripheral T-cell lymphoma: results from the Netherlands Cancer Registry

Clinical Trials & Observations
Mirian Brink, Francien Huisman, Frederik O. Meeuwes, Marjolein W. M. van der Poel, Marie José Kersten, Mariëlle Wondergem, Lara Böhmer, F. J. Sherida H. Woei-A-Jin, Otto Visser, Rimke Oostvogels, Patty M. Jansen, Arjan Diepstra, Tjeerd J. F. Snijders, Gerwin Huls, Joost S. P. Vermaat, Wouter J. Plattel, Marcel Nijland
Journal: Blood Advances
Blood Adv (2024) 8 (14): 3619–3628.
https://doi.org/10.1182/bloodadvances.2023012531
Published: 2024
Includes: Supplemental data
Journal Articles

Sinonasal DLBCL: molecular profiling identifies subtypes with distinctive prognosis and targetable genetic features

Patrick R. G. Eriksen, Fleur de Groot, Erik Clasen-Linde, Peter de Nully Brown, Ruben de Groen, Linea C. Melchior, Andrea D. Maier, Marthe Minderman, Joost S. P. Vermaat, Christian von Buchwald, Steven T. Pals, Steffen Heegaard
Journal: Blood Advances
Blood Adv (2024) 8 (8): 1946–1957.
https://doi.org/10.1182/bloodadvances.2023011517
Published: 2024
Includes: Supplemental data
Journal Articles

Inflammatory reactions mimic residual or recurrent lymphoma on [ 18 F]FDG-PET/CT after CD19-directed CAR T-cell therapy

Janneke W. de Boer, Elise R. A. Pennings, Ankie Kleinjan, Jaap A. van Doesum, Anne M. Spanjaart, Pim G. N. J. Mutsaers, Margot Jak, Marjolein W. M. van der Poel, Maria T. Kuipers, Judit A. Adam, Arjan Diepstra, Lianne Koens, Suzanne van Dorp, Joost S. P. Vermaat, Anne G. H. Niezink, Marie José Kersten, Tom van Meerten
Journal: Blood Advances
Blood Adv (2023) 7 (21): 6710–6716.
https://doi.org/10.1182/bloodadvances.2023010665
Published: 2023
Journal Articles

A significant proportion of classic Hodgkin lymphoma recurrences represents clonally unrelated second primary lymphoma

Diede A. G. van Bladel, Wendy B. C. Stevens, Leonie I. Kroeze, Ruben A. L. de Groen, Fleur A. de Groot, Jessica L. M. van der Last-Kempkes, Madeleine R. Berendsen, Jos Rijntjes, Jeroen A. C. W. Luijks, Irina Bonzheim, Ellen van der Spek, Wouter J. Plattel, Johannes F. M. Pruijt, Susan D. P. W. M. de Jonge-Peeters, Gerjo A. Velders, Chantal Lensen, Esther R. van Bladel, Birgit Federmann, Brigiet M. Hoevenaars, Agata Pastorczak, Jutte van der Werff ten Bosch, Joost S. P. Vermaat, Peet T. G. A. Nooijen, Konnie M. Hebeda, Falko Fend, Arjan Diepstra, J Han J. M. van Krieken, Patricia J. T. A. Groenen, Michiel van den Brand, Blanca Scheijen
Journal: Blood Advances
Blood Adv (2023) 7 (19): 5911–5924.
https://doi.org/10.1182/bloodadvances.2023010412
Published: 2023
Includes: Supplemental data
Journal Articles

Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma: a Dutch population-based study

Clinical Trials & Observations
Mirian Brink, Xaver U. Kahle, Joost S. P. Vermaat, Josee M. Zijlstra, Martine Chamuleau, Marie José Kersten, Müjde Durmaz, Wouter J. Plattel, Pieternella J. Lugtenburg, Wendy Stevens, Rogier Mous, Elisabeth G. E. de Vries, Marjolein W. M. van der Poel, Prashant V. Nannan Panday, Gerwin Huls, Tom van Meerten, Marcel Nijland
Journal: Blood Advances
Blood Adv (2021) 5 (15): 2958–2964.
https://doi.org/10.1182/bloodadvances.2021004295
Published: 2021
Includes: Supplemental data